Price $8.73 |
Market Cap
1.51B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
817.88
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-102.6K
|
FCF
-0.6
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-265.60%
|
ROI
-132.10%
|
|
ROA
-45.50%
|
EPS Growth
28.90%
|
Current Ratio
4.7
|
Debt/Equity
2.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $28.49 | - | - | 10B | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.41 | - | - | 15.9M | Strong Buy |
| Psychemedics Corp. (PMD) | $8.36 | - | - | 46.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.85 | - | - | 95.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.84 | - | - | 284.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
